文献速递心境障碍

θ爆发刺激治疗抑郁症:系统综述与网络及配对荟萃分析

Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis.
PubMed 文献 · Mol Psychiatry · 2024-06-06

该系统综述与随机效应模型网络荟萃分析纳入23项随机对照试验(n=960,平均年龄41.88岁,女性占60.78%),评估六种θ爆发刺激(TBS)方案对抑郁症的疗效与安全性。与伪刺激相比,cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)和iTBS(枕叶)的应答率更高,前两者在抑郁症状改善上占优,iTBS(左背外侧前额叶皮层)缓解率更高;全因停药率、转躁发生率和头痛/治疗部位不适发生率在各方案与伪刺激间无显著差异。

要点

  • cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)与iTBS(左背外侧前额叶皮层)对抑郁症显示有利的风险-获益平衡。
  • 与伪刺激相比,cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)和iTBS(枕叶)的应答率更高(k=23)。
  • 全因停药率(k=17)、转躁发生率(k=7)和头痛/治疗部位不适发生率(k=10)在各TBS方案与伪刺激间均无显著差异。

核心结论

  • cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)与iTBS(左背外侧前额叶皮层)对抑郁症治疗显示有利的风险-获益平衡。

研究设计与样本

  • 系统综述与随机效应模型网络荟萃分析,纳入23项随机对照试验,共960例,平均年龄41.88岁,女性占60.78%。
  • 约69.57%的试验仅纳入重性抑郁障碍患者。
  • 评估六种TBS方案:cTBS(右背外侧前额叶皮层)、cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)+iTBS(右背外侧前额叶皮层)、iTBS(左背内侧前额叶皮层)+iTBS(右背内侧前额叶皮层)、iTBS(枕叶)。
  • 主要结局为应答率,次要结局包括抑郁症状改善、缓解率、全因停药率、转躁发生率和头痛/治疗部位不适发生率。

主要发现

  • 与伪刺激相比,cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)和iTBS(枕叶)的应答率更高(k=23)。
  • cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)和iTBS(左背外侧前额叶皮层)在抑郁症状改善上占优(k=23)。
  • iTBS(左背外侧前额叶皮层)的缓解率更高(k=15)。
  • 全因停药率(k=17)、转躁发生率(k=7)和头痛/治疗部位不适发生率(k=10)在任何TBS方案与伪刺激之间均无显著差异。

关键数值与推荐

  • 应答率分析纳入k=23项试验,cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)、iTBS(左背外侧前额叶皮层)和iTBS(枕叶)优于伪刺激。
  • 抑郁症状改善分析纳入k=23项试验,cTBS(右背外侧前额叶皮层)+iTBS(左背外侧前额叶皮层)和iTBS(左背外侧前额叶皮层)占优。
  • 缓解率分析纳入k=15项试验,iTBS(左背外侧前额叶皮层)优于伪刺激。
  • 全因停药率(k=17)、转躁发生率(k=7)、头痛/治疗部位不适发生率(k=10)在各TBS方案与伪刺激间均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In clinical practice, theta burst stimulation (TBS) presents as a more efficient and potentially more effective therapeutic modality than conventional repetitive transcranial magnetic stimulation (rTMS), as it allows for the delivery of more stimuli in less time and at similar intensities. To date, accelerated treatment plans according to various continuous (cTBS) and intermittent TBS (iTBS) protocols for depression have been proposed. To investigate which of the TBS protocols provided a favorable risk-benefit balance for individuals with depression, this systematic review and random-effects model network meta-analysis was conducted. The study outcomes included response rate (primary), depression symptom improvement, remission rate, all-cause discontinuation rate, incidence of switch to mania, and incidence of headache/discomfort at treatment site. In this meta-analysis, a total of 23 randomized controlled trials (n = 960, mean age = 41.88 years, with 60.78% females) were included. Approximately 69.57% of the trials included individuals with an exclusive diagnosis of major depressive disorder. The following six TBS protocols (target) were evaluated: cTBS (right-dorsolateral prefrontal cortex [R-DLPFC]), cTBS (R-DLPFC) + iTBS (left-DLPFC [L-DLPFC]), iTBS (L-DLPFC), iTBS (L-DLPFC) + iTBS (R-DLPFC), iTBS (left-dorsomedial prefrontal cortex) + iTBS (right-dorsomedial prefrontal cortex), and iTBS (occipital lobe). Compared to sham, cTBS (R-DLPFC) + iTBS (L-DLPFC), iTBS (L-DLPFC), and iTBS (occipital lobe) had a higher response rate (k = 23); cTBS (R-DLPFC) + iTBS (L-DLPFC) and iTBS (L-DLPFC) dominated in the depression symptom improvement (k = 23); and iTBS (L-DLPFC) had a higher remission rate (k = 15). No significant differences were found for all-cause discontinuation rate (k = 17), incidence of switch to mania (k = 7), and incidence of headache/discomfort at treatment site (k = 10) between any TBS protocols and sham. Thus, cTBS (R-DLPFC) + iTBS (L-DLPFC) and iTBS (L-DLPFC) demonstrate favorable risk-benefit balance for the treatment of depression.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kishi T, Ikuta T, Sakuma K, et al. Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis. Mol Psychiatry. 2024. PMID: 38844532. doi:10.1038/s41380-024-02630-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。